On May 21, 2021, Dr. Earl Brien resigned as a director of CytRx Corporation (the 'Company'). Dr. Brien’s resignation was not in connection with any disagreement with the Company on any matter relating to the Company’s operation, policies or practices. Dr. Brien’s term as a director was set to expire at the Company’s forthcoming annual shareholders meeting.